Advances in radiomics for predicting and managing xerostomia following radiotherapy: A systematic review
Abstract
Background: Radiomics has emerged as a promising approach for predicting radiotherapy (RT)- induced xerostomia in head and neck cancer (HNC) patients, potentially enabling more personalized treatment strategies.
Methods: This systematic review was conducted in accordance with PRISMA guidelines and protocol registered in PROSPERO (CRD420251039081). A comprehensive search of PubMed, Scopus, Web of Science, and the Cochrane Library was done between January 2010 and April 2025. Also, quality assessment of included studies was performed using the radiomics quality score (RQS) tool.
Results: This systematic review included 32 eligible studies with 4,167 HNC patients. The RQS ranged from 7 to 33 out of 36, with a mean of 15.13 (42.0 %). A dose-dependent relationship between radiation dose and xerostomia severity was observed. V30 > 50 % and V40 > 60 % doses to the parotids were associated with moderate-to-severe xerostomia (Grades 2-3), affecting 50 % of patients in some studies. IMRT still resulted in moderate-to-severe xerostomia when these dose thresholds were exceeded. Additionally, submandibular glands were also critical, especially with V40 > 60 % doses. Delta-radiomics refers to the analysis of changes in radiomic features over time, typically before and after treatment, to assess tissue response. Delta-radiomics outperformed static radiomics most of studies, particularly with MRI or MVCT. The highest performance was reported with an AUC of 0.97 for a CT + MRI ensemble…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 4,167 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.